Long-term monitoring may be needed in patients who undergo lensectomies for childhood cataract, and a possible link is seen between statin use and certain glaucoma types.

DALLAS — Blue Zones and the American College of Lifestyle Medicine developed a certification process designed to equip physicians with tools to address chronic disease using evidence-based lifestyle medicine interventions. The course combines the American College of Lifestyle Medicine’s (ACLM’s) expertise in therapeutic lifestyle medicine, like optimal nutrition, physical activity and stress management, with Blue Zones’ information on regions of the world, dubbed “blue zones,” that are heavily populated with people who experience lasting longevity and

In our study, we compared data before and after surgery and also added a comparison with the manufacturer – provided normative dataset.

DALLAS — Blue Zones and the American College of Lifestyle Medicine developed a certification process designed to equip physicians with tools to address chronic disease using evidence-based lifestyle medicine interventions. The course combines the American College of Lifestyle Medicine’s (ACLM’s) expertise in therapeutic lifestyle medicine, like optimal nutrition, physical activity and stress management, with Blue Zones’ information on regions of the world, dubbed “blue zones,” that are heavily populated with people who experience lasting longevity and

A 7-year-old boy presented with a two-year history of a slowly enlarging subconjunctival mass, without‌ trauma. Slit-lamp examination showed a well-circumscribed, pinkish-white lesion visible only on nasal gaze (A), with limited mobility and no tenderness to palpation. Orbital computed tomography demonstrated a hyperdense lesion adjacent to the temporal aspect of the left globe (B). Surgical excision was performed, revealing a flat, smooth, firm white mass measuring approximately 6 × 3 mm (C), which was densely adherent to the sclera.

Stevens-Johnson syndrome is a mucocutaneous immune-mediated hypersensitivity reaction. It is often triggered by drugs or infections. It presents as a skin and mucous membrane drug hypersensitivity reaction with variable severity. Stevens-Johnson syndrome (SJS) is a mild variant that affects less than 10% of the body surface area whereas toxin epidermal necrolysis is a potentially life-threatening severe form that involves more than 30% of the body surface area. The estimated incidence of SJS is one to six cases per million person-years. The main etiology is drug induced in about 75% of cases,

A 55-year-old white man with a medical history of well-controlled type 2 diabetes, rheumatoid arthritis and fibromyalgia presented with progressively worsening, painless decline in vision of both eyes. His ocular history was notable for keratoconus in both eyes, managed with contact lenses. Two weeks earlier, he noticed darkening of his vision, “like looking through a dark curtain.” He also noted onset of vesicular lesions at the corner of both eyes, along with one vesicular lesion on the left upper eyelid, prompting presentation to a local eye doctor. After evaluation, he was suspected of

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology. This month we are discussing a specific case: A pilot who previously underwent LASIK presents now with a dense cataract as well as an epiretinal membrane (ERM) that requires surgery. Due to his previous LASIK, he is interested in the Light Adjustable Lens (LAL, RxSight). His goal is to achieve the highest possible level of uncorrected visual acuity, and he is willing to invest both financially and

Age-related dementia, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy and hearing loss are all more common in the elderly patient. The average age of onset of a cataract in the U.S. is about 60 years and for cataract/IOL surgery, 74 years. The average age of onset for age-related dementia is 70 years, for glaucoma 55 years, for AMD 60 years, and for diabetic retinopathy in adult-onset diabetes 65 years. All of these age-related diseases tend to progress with increasing age. A patient who presents for cataract/IOL surgery in their 70s has a 10% to 15% chance of having

Click here to read the Cover Story, “Cataract surgery lessens risk, development and burden of dementia.” There are currently more than 55 million people worldwide living with dementia, and this number is projected to double every 20 years. Dementia is a multifaced and multifactorial condition, and the PrOVIDe study (Bowen et al.) showed that about one-third of people affected have visual acuity lower than 20/50, which makes it difficult for them to process information visually. For some patients, spectacles can help, but in the majority of cases, the cause of reduced vision is untreated

Dementia is a highly prevalent condition, affecting 57 million people worldwide, with nearly 10 million new cases each year, according to a recent WHO report. In 2020, the Lancet Commission on dementia identified 12 modifiable risk factors: less education, hearing loss, hypertension, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol consumption, traumatic brain injury, air pollution and social isolation. In a 2024 update, two new evidence-based risk factors were added: high cholesterol and vision loss. Vision loss that occurs around the age at which dementia often

Age-related dementia, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy and hearing loss are all more common in the elderly patient. The average age of onset of a cataract in the U.S. is about 60 years and for cataract/IOL surgery, 74 years. The average age of onset for age-related dementia is 70 years, for glaucoma 55 years, for AMD 60 years, and for diabetic retinopathy in adult-onset diabetes 65 years. All of these age-related diseases tend to progress with increasing age. A patient who presents for cataract/IOL surgery in their 70s has a 10% to 15% chance of having

It’s been nearly 1 year since Healio Community opened its proverbial doors to health care professionals looking to connect with colleagues and support their personal and professional wellness. As the first year comes to an end, the Healio Community team is looking back at highlights and looking forward to what’s to come. We hope you’ll join us. Some of the most important topics for our members center on personal and professional growth and wellness. From Book Club author chats to actionable webinars, here are the most attended events of 2025: Author Chat with Eric Topol, MD: Super Agers In this

It’s been nearly 1 year since Healio Community opened its proverbial doors to health care professionals looking to connect with colleagues and support their personal and professional wellness. As the first year comes to an end, the Healio Community team is looking back at highlights and looking forward to what’s to come. We hope you’ll join us. Some of the most important topics for our members center on personal and professional growth and wellness. From Book Club author chats to actionable webinars, here are the most attended events of 2025: Author Chat with Eric Topol, MD: Super Agers In this

To compare the histological effects of standard ECP, the novel ECP device and TCP on the ciliary body and surrounding structures in human cadaveric eyes.

Publication date: Available online 5 December 2025 Source: Experimental Eye Research Author(s): Do Young Park, Jeong-hun Mok, Jong Chul Han

Publication date: Available online 4 December 2025 Source: Experimental Eye Research Author(s): Xiaopan Zhang, Liang Liu, Shaoqiang Han, Xuemin Jin, Xingzheng Pan, Jessica L. Gu, Yong Zhang, Jingliang Cheng, Bin Zhang, Baohong Wen

Publication date: Available online 4 December 2025 Source: Experimental Eye Research Author(s): Apurva Yadav, Rajesh Choudhary, Anshul Ram, Umashankar Nirmalkar, Jaya Shree, Swarnali Das Paul, Vinay Sagar Verma

.

.

.

Publication date: Available online 4 December 2025 Source: Progress in Retinal and Eye Research Author(s): Yue Wu, Cecilia S. Lee, Aaron Y. Lee

Publication date: November 2025 Source: Progress in Retinal and Eye Research, Volume 109 Author(s):

Publication date: Available online 5 December 2025 Source: AJO International Author(s): Risa Araki, Yohei Tomita, Tomonori Yuda, Xiaoyan Jiang, Norimitsu Ban, Hiromitsu Kunimi, Atsuro Uchida, Toshihide Kurihara, Hajime Shinoda, Kazuno Negishi

Publication date: Available online 1 December 2025 Source: AJO International Author(s): Hye Won Jun, Sun Young Ryu, Tae Keun Yoo